Cargando…

Relationship between treatment delay and final infarct size in STEMI patients treated with abciximab and primary PCI

BACKGROUND: Studies on the impact of time to treatment on myocardial infarct size have yielded conflicting results. In this study of ST-Elevation Myocardial Infarction (STEMI) treated with primary percutaneous coronary intervention (PCI), we set out to investigate the relationship between the time f...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tödt, Tim, Maret, Eva, Alfredsson, Joakim, Janzon, Magnus, Engvall, Jan, Swahn, Eva
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3359186/ https://www.ncbi.nlm.nih.gov/pubmed/22361039 http://dx.doi.org/10.1186/1471-2261-12-9

Ejemplares similares

Relationship between the duration of ischemia and final infarct size in STEMI patients treated with abciximab and primary PCI
por: Tödt, Tim, et al.
Publicado: (2012)

Strategies TO reduce time delays in patients with AcuTe coronary heart disease treated with primary PCI—the STOP WATCH study: a multistage action research project
por: Tödt, Tim, et al.
Publicado: (2013)

High Bolus Tirofiban vs Abciximab in Acute STEMI Patients Undergoing Primary PCI – The Tamip Study
por: Balghith, Mohammed A.
Publicado: (2012)

Time trends in STEMI—improved treatment and outcome but still a gender gap: a prospective observational cohort study from the SWEDEHEART register
por: Lawesson, Sofia Sederholm, et al.
Publicado: (2012)

Functional measurements based on feature tracking of cine magnetic resonance images identify left ventricular segments with myocardial scar
por: Maret, Eva, et al.
Publicado: (2009)

Glomerular filtration rate (GFR) during and after STEMI: a single-centre, methodological study comparing estimated and measured GFR
por: Venetsanos, Dimitrios, et al.
Publicado: (2015)

Prevalence and prognostic impact of chronic kidney disease in STEMI from a gender perspective: data from the SWEDEHEART register, a large Swedish prospective cohort
por: Sederholm Lawesson, Sofia, et al.
Publicado: (2015)

Long term risk and costs of bleeding in men and women treated with triple antithrombotic therapy–An observational study
por: Holm, Anna, et al.
Publicado: (2021)

Computed tomography coronary angiography in patients with acute myocardial infarction and normal invasive coronary angiography
por: Panayi, Georgios, et al.
Publicado: (2016)

Association between gender and short-term outcome in patients with ST elevation myocardial infraction participating in the international, prospective, randomised Administration of Ticagrelor in the catheterisation Laboratory or in the Ambulance for New ST elevation myocardial Infarction to open the Coronary artery (ATLANTIC) trial: a prespecified analysis
por: Venetsanos, Dimitrios, et al.
Publicado: (2017)

Abciximab: Abciximab-induced alveolar haemorrhage: case report
Publicado: (2021)

Infarct burden following multivessel PCI vs. infarct-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
por: Mangion, Kenneth, et al.
Publicado: (2015)

Bleeding complications with clopidogrel or ticagrelor in ST-elevation myocardial infarction patients – A real life cohort study of two treatment strategies()
por: Alfredsson, Joakim, et al.
Publicado: (2020)

Evaluation of an AI-based, automatic coronary artery calcium scoring software
por: Sandstedt, Mårten, et al.
Publicado: (2019)

Could TnI level on admission predict function and infarct size in STEMI patient treated with pPCI – CMR study
por: Piotrowska-Kownacka, Dorota, et al.
Publicado: (2009)

Phase analysis and mechanical dispersion perform equally in the detection of myocardial scar on cine magnetic resonance imaging
por: Maret, Eva, et al.
Publicado: (2011)

Delayed PCI is not beneficial for STEMI patients with impaired renal function: a retrospective cohort study
por: Lao, Yi, et al.
Publicado: (2023)

High levels of interleukin-6 are associated with final infarct size and adverse clinical events in patients with STEMI
por: Tøllefsen, Ingvild Maria, et al.
Publicado: (2021)

Incidence, delays, and outcomes of STEMI during COVID‐19 outbreak: Analysis from the France PCI registry
por: Rangé, Grégoire, et al.
Publicado: (2020)

Left ventricular outcomes following multivessel PCI vs. infarct artery-only PCI in patients with acute STEMI: the Glasgow PRAMI CMR sub-study
por: Mangion, Kenneth, et al.
Publicado: (2015)

New guidelines on primary PCI for patients with STEMI: changing insights
por: van der Wall, E.E.
Publicado: (2015)

Will intravenous paracetamol crush fentanyl in patients undergoing PCI for STEMI?
por: ten Berg, J. M., et al.
Publicado: (2019)

Effect of prehospital treatment in STEMI patients undergoing primary PCI
por: Fabris, Enrico, et al.
Publicado: (2022)

Soluble TNF Receptors Are Associated with Infarct Size and Ventricular Dysfunction in ST-Elevation Myocardial Infarction
por: Nilsson, Lennart, et al.
Publicado: (2013)

Infarct size following complete revascularization in patients presenting with STEMI: a comparison of immediate and staged in-hospital non-infarct related artery PCI subgroups in the CvLPRIT study
por: Khan, Jamal N., et al.
Publicado: (2016)

Alveolar Hemorrhage during Abciximab Infusion
por: Koza, Yavuzer, et al.
Publicado: (2021)

Prehospital and in-hospital delays to care and associated factors in patients with STEMI: an observational study in 101 non-PCI hospitals in China
por: Feng, Lin, et al.
Publicado: (2019)

Effect of Abciximab on the Levels of Circulating Microparticles in Patients with Acute Myocardial Infarction Treated by Primary Angioplasty
por: Cha, Jung-Joon, et al.
Publicado: (2013)

Role of tirofiban with dual antiplatelet therapy in patients with STEMI undergoing primary PCI
por: Türker, Yasin
Publicado: (2016)

Impact of periprocedural morphine use on mortality in STEMI patients treated with primary PCI
por: Domokos, Dominika, et al.
Publicado: (2021)

Complementary Pharmacotherapy for STEMI Undergoing Primary PCI: An Evidence-Based Clinical Approach
por: Fabris, Enrico, et al.
Publicado: (2022)

BMI Modifies Increased Mortality Risk of Post-PCI STEMI Patients with AKI
por: Schvartz, Reut, et al.
Publicado: (2022)

LEFT LATERAL VIEW FOR PCI TREATMENT OF INFERIOR STEMI IN A PATIENT WITH DEXTROCARDIA
por: Katić, Josip, et al.
Publicado: (2022)

Complete revascularization with PCI in STEMI patients with multivessel disease, when is the appropriate time?
por: Aquino-Bruno, Heberto, et al.
Publicado: (2023)

Preventive PCI versus culprit lesion stenting during primary PCI in acute STEMI: a systematic review and meta-analysis
por: Pandit, Anil, et al.
Publicado: (2014)

Safety and efficacy of abciximab as an adjunct to percutaneous coronary intervention
por: Vergara-Jimenez, Jennifer, et al.
Publicado: (2010)

Abciximab: a reappraisal of its use in coronary care
por: Valgimigli, Marco, et al.
Publicado: (2008)

A prospective, observational, multicentre study comparing tenecteplase facilitated PCI versus primary PCI in Indian patients with STEMI (STEPP—AMI)
por: Victor, Suma M, et al.
Publicado: (2014)

Usefulness of Haemoglobin Level Combined with CAMI-STEMI Score for Predicting MACCE in Patients with Acute ST-Elevation Myocardial Infarction after PCI
por: Tang, Chengchun, et al.
Publicado: (2019)

The effects of tirofiban infusion on clinical and angiographic outcomes of patients with STEMI undergoing primary PCI
por: Kaymaz, Cihangir, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_3muoqohbi5l6eu5tltcj730okv